Vanda Pharmaceuticals (NASDAQ: VNDA) opened some 45% higher today after the biotech firm said it has received the FDA’s approval for its
Nvidia stock (NASDAQ: NVDA) ticked higher on Monday as Wall Street headed into the chipmaker’s Feb. 25 earnings report with expectations already
The race to the moon is on — again. But the strategic competition playing out today is much bigger than our race
Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ambitions as it prepares to enter public markets in the
Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into a fallen
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across
Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now hovering at
Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder
In a sweeping and provocative macro-analysis titled "The 2028 Global Intelligence Crisis," Citrini Research has outlined a sobering vision of a financial
Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in
